ArticleThe Journal of infection2022

Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.

Bin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.